1
Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome
Condition(s):Wiskott-Aldrich SyndromeLast Updated:May 6, 2020Recruiting
Romiplostim: 72 Clinical Trials, Page 1 of 8
Hide Studies Not Open or Pending
2
Using Romiplostim to Treat Low Platelet Counts During Chemotherapy in People With Lymphoma
Condition(s):Lymphoma Patients; ThrombocytopeniaLast Updated:December 17, 2020Recruiting
3
An Observational Study to Evaluate the Efficacy of Biweekly Romiplostim in Adult Patients With ITP
Condition(s):Immune ThrombocytopeniaLast Updated:January 14, 2015Unknown status
4
Using Romiplostim to Treat Low Platelet Counts Following Chemotherapy and Autologous Hematopoietic Cell Transplantation in People With Blood Cancer
Condition(s):Multiple Myeloma; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; HDT-AHCTLast Updated:March 26, 2021Recruiting
5
Safety of Romiplostim (Nplate®) Following UCBT
Condition(s):Hematologic MalignanciesLast Updated:April 21, 2020Active, not recruiting
6
Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)
Condition(s):Immune ThrombocytopeniaLast Updated:August 24, 2020Completed
7
Romiplostim Treatment for Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome.
Condition(s):Wiskott-Aldrich SyndromeLast Updated:December 28, 2020Completed
8
A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors
Condition(s):Solid Tumor; Solid Tumor, Childhood; Solid CarcinomaLast Updated:February 2, 2021Recruiting
9
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or Breast Cancer
Condition(s):Chemotherapy-induced ThrombocytopeniaLast Updated:April 22, 2021Recruiting
10
Immunomodulation With Romiplostim in Young Adults With ITP
Condition(s):Immune ThrombocytopeniaLast Updated:May 7, 2020Completed